Ampio Pharm Stock Performance
| AMPE Stock | USD 0.28 -0.01 -3.45% |
Ampio Pharm holds a performance score of 21 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 95.0, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ampio Pharm will likely underperform. Use Ampio Pharm sortino ratio and the relationship between the potential upside and day typical price, to analyze future returns on Ampio Pharm.
Risk-Adjusted Performance
Constructive
Weak | Strong |
Compared with the broader market, risk-adjusted returns on Ampio Pharm rank lower than 21% of all global equities and portfolios over the last 90 days. This score becomes more useful when investors compare it with downside risk, Sharpe Ratio, and current trend stability. In spite of rather unfluctuating basic indicators, Ampio Pharm exhibited solid returns over the last few months and may actually be approaching a breakup point. Learn More
| Begin Period Cash Flow | 12.7 M | |
| Free Cash Flow | -8.6 M |
Ampio |
Ampio Pharm Relative Risk vs. Return Landscape
If you had invested $ 0.52 in Ampio Pharm on December 12, 2025 and sold it today you would have earned a total of $ 27.48 from holding Ampio Pharm or generated 5284.62% return on investment over 90 days. Ampio Pharm is currently generating a 65.9981% daily expected return and carries 243.3969% risk (volatility on return distribution) over a 90-day horizon. In different words, most equities are less risky than Ampio, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Target Price Odds to finish over Current Price
Historical analysis shows that Ampio Pink Sheet price tends to gravitate toward a long-run average, consistent with the well-known mean reversion effect. While this is useful for forecasting, some stocks are persistently mispriced, often reflecting additional risk factors that justify the observed spread.
| Current Price | Horizon | Target Price | Odds moving above the current price in 90 days |
| 0.28 | 90 days | 0.28 | under 4 |
Based on our quantitative model, the chance of Ampio Pharm moving above the current price in 90 days from now is under 4 (This distribution for Ampio Pharm illustrates how likely Ampio Pink Sheet is to reach various price levels over 90 days).
Ampio Pharm Price Density |
| Price |
Predictive Modules for Ampio Pharm
Investors analyzing Ampio Pharm can draw on many different pink sheet market forecasting techniques. While no approach eliminates uncertainty, comparing the outputs of diverse models helps investors calibrate expectations and make more informed decisions in the face of market unpredictability.The mean reversion framework for Ampio Pharm is built on the premise that markets are not perfectly efficient and that prices periodically overshoot their intrinsic value in both directions.
Primary Risk Indicators
Investors in the pink sheet market have faced considerable volatility over the past two decades. Ampio Pharm has reflected this environment with periods of sharp price declines and strong recoveries. Tracking Ampio Pharm's fundamental risk indicators and adjusting hedges accordingly can help protect portfolios that include Ampio Pharm.α | Alpha over Dow Jones | 383.76 | |
β | Beta against Dow Jones | 95.00 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | 0.33 |
Ampio Pharm Alerts and Suggestions
Alerts for Ampio Pharm are designed to surface the most relevant stock developments for investors. Ampio Pharm notifications flag significant changes in market conditions, fundamentals, and technical signals that may require action.| Ampio Pharm is way too risky over 90 days horizon | |
| Ampio Pharm has some characteristics of a very speculative penny stock | |
| Ampio Pharm appears to be risky and price may revert if volatility continues | |
| Ampio Pharm has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was -8.63 M with profit before overhead, payroll, taxes, and interest of 0. | |
| Ampio Pharm currently holds about 23.25 M in cash with -8.56 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. |
Ampio Pharm Price Density Drivers
Price movements in Ampio Pharm are influenced by the tension between bullish and bearish market participants. When short-sellers increase pressure, long holders often reassess their positions, driving volatility higher. Key market indicators are shown below.
| Common Stock Shares Outstanding | 810.1 K | |
| Cash And Short Term Investments | 4.1 M |
Ampio Pharm Fundamentals Growth
The financial health of Ampio Pharm is the primary driver of Ampio Pink Sheet market performance. Investors evaluate revenue trends, earnings growth, profit margins, and debt levels to form their outlook on Ampio Pink Sheet.
| Return On Equity | -1.14 | |||
| Return On Asset | -0.62 | |||
| Current Valuation | -3.33 M | |||
| Shares Outstanding | 1.14 M | |||
| Price To Earning | 28.57 X | |||
| Price To Book | 0.21 X | |||
| EBITDA | -8.63 M | |||
| Cash And Equivalents | 23.25 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 274 K | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 4.03 X | |||
| Cash Flow From Operations | -8.56 M | |||
| Earnings Per Share | -10.66 X | |||
| Total Asset | 5.74 M | |||
| Retained Earnings | -242.53 M | |||
| Current Asset | 29.23 M | |||
| Current Liabilities | 5.52 M | |||
About Ampio Pharm Performance Analysis
Ampio Pharm performance is measured on a risk-adjusted basis against benchmarks. Consistency across periods improves confidence in structural behavior. Ampio Pharm shows ROE of -113.96%, ROA of -61.57%. 
Ellen Johnson · Member of Macroaxis Editorial Board
Unless otherwise specified, financial data for Ampio Pharm is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Updates may occur throughout the day.
Ampio Pink Sheet is Curated By:
Ellen Johnson · Member of Macroaxis Editorial Board